kanamycin a has been researched along with fosfomycin in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (46.15) | 18.7374 |
1990's | 5 (19.23) | 18.2507 |
2000's | 4 (15.38) | 29.6817 |
2010's | 5 (19.23) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Blango, MG; Mulvey, MA | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bardowski, J; Młynarczyk, A; Młynarczyk, G; Osowiecki, H | 1 |
Abe, S; Fujita, K; Murayama, T; Sayama, T; Tashiro, H | 1 |
Stille, W | 1 |
Aikawa, T; Anzai, T; Ohtani, I; Ohtsuki, K; Ouchi, J; Sato, Y | 1 |
Aikawa, T; Anzai, T; Ohtani, I; Ohtsuki, K; Ouchi, J; Saito, T; Sato, Y | 1 |
Amano, M; Furukawa, Y; Okunobo, T; Saito, N; Sone, A; Tanaka, H; Ueda, H; Ura, H | 1 |
Fujita, K | 1 |
Homma, JY; Kasai, T | 1 |
Biolchi, S; Germiniani, R; Limido, P; Maltempi, P; Tajana, A | 1 |
Inouye, S; Koeda, T; Niizato, T; Takeda, U | 1 |
Inouye, S; Komiya, I; Niizato, T; Yamada, Y; Yuda, Y | 1 |
Maruyama, S; Sakata, H | 1 |
Kubo, S; Moriguchi, N; Yagi, K; Yamamoto, T; Yoshioka, K | 1 |
Harada, H; Kita, E; Kurioka, T; Yunou, Y | 1 |
Fujii, J; Taniguchi, H; Yoshida, S; Yoshimura, K | 1 |
Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
Tabata, M; Takata, T; Tsuruoka, T; Watabe, H | 1 |
Ishitobi, J; Kamiya, A; Oie, S; Sawa, A; Tomita, M | 1 |
Cope, EK; Dhungana, S; Finney, KB; Fox, DT; Koppisch, AT; Leid, JG; Phillips, PD; Schmidt, EN; Testa, CA; Tian, H; Valentine, MC; Warrington, NV | 1 |
1 review(s) available for kanamycin a and fosfomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for kanamycin a and fosfomycin
Article | Year |
---|---|
[Comparison of clinical efficacy of fosfomycin (FOM) and kanamycin (KM) in bacillary dysentery by double blind method (author's transl)].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Dysentery, Bacillary; Female; Fosfomycin; Humans; Kanamycin; Male; Middle Aged | 1980 |
[Short-term prevention of surgical infections with antibiotics. Preliminary results of a controlled clinical experimentation].
Topics: Ampicillin; Anti-Bacterial Agents; Clinical Trials as Topic; Fosfomycin; Humans; Kanamycin; Respiratory Tract Infections; Surgical Wound Infection; Urinary Tract Infections | 1982 |
23 other study(ies) available for kanamycin a and fosfomycin
Article | Year |
---|---|
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Chromosomal localization of resistance to fosfomycin and aminocyclitol antibiotics in hospital strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Chromosome Mapping; Chromosomes, Bacterial; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Microbial; Fosfomycin; Genes, Bacterial; Genetic Markers; Gentamicins; Kanamycin; Plasmids; Staphylococcus aureus; Tobramycin; Transduction, Genetic | 1985 |
Age-dependent aminoglycoside nephrotoxicity.
Topics: Acetylglucosaminidase; Adult; Age Factors; Aged; Aminoglycosides; Dibekacin; Female; Fosfomycin; Hexosaminidases; Humans; Kanamycin; Kidney; Male; Middle Aged | 1985 |
The prognostic value of the antibiogram.
Topics: Amniotic Fluid; Ampicillin; Animals; Anti-Bacterial Agents; Bile; Cefaclor; Cephalexin; Escherichia coli Infections; Fosfomycin; Gentamicins; Humans; In Vitro Techniques; Kanamycin; Klebsiella Infections; Microbial Sensitivity Tests; Urine | 1983 |
Mechanism of protective effect of fosfomycin against aminoglycoside ototoxicity.
Topics: Animals; Anti-Bacterial Agents; Dibekacin; Drug Administration Schedule; Ear, Inner; Fosfomycin; Kanamycin; Kidney; Metabolic Clearance Rate; Rats; Rats, Inbred F344 | 1984 |
[Protective effect of fosfomycin against aminoglycoside induced ototoxicity].
Topics: Animals; Anti-Bacterial Agents; Dibekacin; Fosfomycin; Hair Cells, Auditory; Kanamycin; Kidney; Kidney Diseases; Labyrinth Diseases; Rats | 1983 |
[Clinical studies on combination chemotherapy with fosfomycin and dibekacin in complicated urinary tract infection].
Topics: Adult; Aged; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Kanamycin; Male; Middle Aged; Urinary Tract Infections | 1983 |
An effect of fosfomycin on the pharmacokinetics of amikacin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Interactions; Fosfomycin; Intestinal Absorption; Kanamycin; Kidney; Kinetics; Lysosomes; Male; Rats; Rats, Inbred Strains | 1984 |
Synergistic effects of a macrolide and a cell wall-affecting antibiotic on Pseudomonas aeruginosa in vitro and in vivo. 2. Combined effects of a macrolide with a fosfomycin and an aminoglycoside antibiotic.
Topics: Animals; Anti-Bacterial Agents; Cell Wall; Depression, Chemical; Dibekacin; Drug Synergism; Drug Therapy, Combination; Female; Fosfomycin; Kanamycin; Leucomycins; Mice; Pseudomonas aeruginosa; Pseudomonas Infections | 1982 |
Protective effect of fosfomycin on the experimental nephrotoxicity induced by dibekacin.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Chemical Phenomena; Chemistry; Dibekacin; Dose-Response Relationship, Drug; Fosfomycin; Kanamycin; Kidney Diseases; Male; Rats; Rats, Inbred F344; Time Factors | 1982 |
Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rats.
Topics: Animals; Anti-Bacterial Agents; Dehydration; Dibekacin; Fosfomycin; In Vitro Techniques; Kanamycin; Kidney; Kinetics; Lysosomes; Male; Rats; Rats, Inbred Strains | 1982 |
[Result of antibiotic therapy for children with Escherichia coli O26:H11 infection].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Disease Outbreaks; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Japan; Kanamycin; Norfloxacin; Retrospective Studies | 1998 |
[The drug sensitivity of enterohemorragic Escherichia coli and antibiotics treatment for hemorrhagic enterocolitis--from an outbreak of enterocolitis in Sakai city].
Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Disease Outbreaks; Drug Resistance, Microbial; Enterocolitis; Escherichia coli Infections; Escherichia coli O157; Fosfomycin; Humans; Japan; Kanamycin; Penicillins | 1997 |
Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Toxins; Brain Chemistry; Disease Models, Animal; Disease Progression; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Kanamycin; Mice; Mice, Inbred C57BL; Norfloxacin; Protein-Energy Malnutrition; Reference Values; Sensitivity and Specificity; Shiga Toxins; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Colony Count, Microbial; Drug Synergism; Enterotoxins; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Injections, Intraperitoneal; Kanamycin; Male; Mice; Mice, Inbred ICR; Minocycline; Mitomycin; Norfloxacin; Shiga Toxin 2 | 1999 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
[Activity of fosfomycin against Escherichia coli O157:H7--morphological changes and production of Shiga toxins].
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriolysis; Cell Wall; Chloramphenicol; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Kanamycin; Norfloxacin; Shiga Toxins | 2003 |
In vitro bactericidal activity of antimicrobial agents against enterohaemorrhagic Escherichia coli.
Topics: Anti-Bacterial Agents; Cefoperazone; Electrophoresis, Gel, Pulsed-Field; Escherichia coli O157; Fosfomycin; Kanamycin; Microbial Sensitivity Tests; Norfloxacin | 2004 |
Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2.
Topics: Anti-Bacterial Agents; Biosynthetic Pathways; Fosfomycin; Gene Expression Regulation, Bacterial; Hemiterpenes; Humans; Hydrogen Peroxide; Kanamycin; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Organophosphorus Compounds; Oxidative Stress; Salmonella typhimurium; Time Factors | 2014 |